Are you thinking of digitalising your Weighing Room and eliminating paper from all product dispensing and weighing operations?
Specialised solutions are now available on the market to replace manual or semi-manual handling of weighing instructions with computerised management of weighing operations, workflows and the various steps involved. Adopting one of them therefore brings greater efficiency and consistency in operations, as well as thorough control of the materials and equipment used.
What are the benefits?
- Weighing instructions replaced by an electronic guide for managing weighing orders. Paper elimination.
- Improved consistency and repeatability of operations.
- User-friendly: computerised weighing instructions, workflows and sequencing of the various steps.
- Optimised control, modification and monitoring of the area’s SOPs.
- Higher quality as a result of thorough control of the materials and equipment involved in weighing orders.
- Improved planning and adherence to production plans.
- Increased weighing room availability as a result of reduced data transfer, checking and recording times.
- Supports compliance with regulations in regulated environments such as GMP or FDA. Ensures full tracking and Audit Trail (21 CFR Part 11 Compliance) to meet regulatory requirements.
- Integration with ERP enterprise resource planning systems as well as field devices (scales, barcode readers, etc.).
Send us an email at info@oytec.es or use the form below and we will give you a technical demonstration of a standard GAMP5 CAT4 solution for Electronic Weighing.
Latest News
Fast & Furious eBR Implementation
YES, that's right, a Fast & Furious eBR Implementation is possible. It is no longer a utopia to carry out an Electronic Batch Record implementation in a fast and massive way for any manufacturing plant. Regardless of the manufacturing area: bulk, weighing, or...
EMA and FDA: The 10 Principles of Pharmaceutical AI
The European Union and the United States published the Guiding Principles for Good AI Practices in Drug Development on January 14, 2026, as part of a strategic effort to harmonize regulatory criteria. The EMA-FDA collaborative work initiative has the mission of...
The FDA and Pharmaceutical AI: Key Points from the 2025 Draft on Model Credibility
The FDA positions credibility as an indispensable condition for utilising AI in pharmaceutical regulatory decision-making, within a risk-proportionate framework that demands traceability, transparency and validation throughout the entire model lifecycle. This approach...




